Incyte Corporation (INCY) has 20 known insider and institutional holders on record. The largest holder is BAKER FELIX with 2,944,621 shares. Other notable holders include BAKER BROS. ADVISORS LP and Hoppenot Herve.
Over the last 12 months, insiders have made 69 transactions in INCY stock — 27 buys (valued at $12.93M) and 15 sells (valued at $31.59M). Insider buying has outpaced selling during this period, which may signal confidence in the company's prospects.
INCY Insider Ownership
Top Holder
BAKER FELIX
2,944,621 shares
Buys (12 mo)
27
$12.93M value
Sells (12 mo)
15
$31.59M value
12-Month Transaction Activity
Top Insider Holders
| # |
Name |
Role |
Shares Owned |
Last Filed |
Relative Size |
| 1 |
Baker Felix |
Director |
2,944,621 |
2022-10-04 |
|
| 2 |
Baker Bros. Advisors Lp |
10 Percent Owner |
2,818,039 |
2026-04-02 |
|
| 3 |
Hoppenot Herve |
Director |
326,803 |
2025-12-10 |
|
| 4 |
Stamoulis Christiana |
EVP & Chief Financial Officer |
110,123 |
2025-04-03 |
|
| 5 |
Swain Paula J |
EVP, Human Resources |
96,362 |
2025-04-03 |
|
| 6 |
Flannelly Barry P |
EVP & General Manager Us |
44,726 |
2025-04-03 |
|
| 7 |
Iyengar Vijay K |
EVP, Gmapps |
41,817 |
2025-04-03 |
|
| 8 |
Heeson Lee |
EVP, Head of Incyte Intl |
38,041 |
2026-02-04 |
|
| 9 |
Dickinson Jonathan Elliott |
EVP, General Manager, Europe |
36,390 |
2024-09-16 |
|
| 10 |
Morrissey Michael James |
EVP, Head of Tech. Operations |
34,065 |
2026-02-04 |
|
| 11 |
Clancy Paul J |
Director |
23,741 |
2026-04-02 |
|
| 12 |
Harrigan Edmund |
Director |
21,122 |
2026-04-02 |
|
| 13 |
Pasquale Maria E |
EVP & General Counsel |
20,275 |
2023-07-18 |
|
| 14 |
Stein Steven H |
EVP & Chief Medical Officer |
19,932 |
2026-01-21 |
|
| 15 |
Dixon Wendy L |
Director |
17,768 |
2022-04-04 |
|
| 16 |
Dhanak Dashyant |
EVP & Chief Scientific Officer |
16,896 |
2023-07-18 |
|
| 17 |
Wenqing Yao |
EVP, Head of Discovery Chem |
15,054 |
2021-07-07 |
|
| 18 |
Trotta Matteo |
EVP, GM, Dermatology Us |
14,882 |
2026-03-26 |
|
| 19 |
Issa Mohamed Khairie |
EVP, Head of Us Oncology |
14,237 |
2026-01-21 |
|
| 20 |
Friedman Paul A |
Director |
10,514 |
2020-05-28 |
|
Recent Transactions (last 12 months)
| Date |
Name |
Role |
Type |
Shares |
Price |
Value |
| 2026-03-31 |
Clancy Paul J |
Director |
RSU Award |
265 |
$94.12 |
$24.94K |
| 2026-03-31 |
Baker Bros. Advisors Lp |
10 Percent Owner |
RSU Award |
421 |
- |
- |
| 2026-03-31 |
Harrigan Edmund |
Director |
RSU Award |
269 |
$94.12 |
$25.32K |
| 2026-03-25 |
Trotta Matteo |
EVP, GM, Dermatology Us |
Tax Withholding of RSU |
537 |
$92.23 |
$49.53K |
| 2026-03-17 |
Cagnoni Pablo J |
President, R&d |
Option Exercise (Sell) |
7,166 |
$61.18 |
$438.42K |
| 2026-02-19 |
Cagnoni Pablo J |
President, R&d |
Option Exercise (Sell) |
13,093 |
$61.76 |
$808.62K |
| 2026-02-02 |
Heeson Lee |
EVP, Head of Incyte Intl |
Tax Withholding of RSU |
111 |
$102.67 |
$11.4K |
| 2026-02-02 |
Morrissey Michael James |
EVP, Head of Tech. Operations |
Tax Withholding of RSU |
185 |
$102.67 |
$18.99K |
| 2026-01-16 |
Mayes Patrick A |
EVP & Chief Scientific Officer |
RSU Award |
4,218 |
$106.21 |
$447.99K |
| 2026-01-16 |
Issa Mohamed Khairie |
EVP, Head of Us Oncology |
RSU Award |
14,237 |
$106.21 |
$1.51M |
| 2026-01-16 |
Heeson Lee |
EVP, Head of Incyte Intl |
RSU Award |
8,911 |
- |
- |
| 2026-01-16 |
Trotta Matteo |
EVP, GM, Dermatology Us |
RSU Award |
8,542 |
$106.21 |
$907.25K |
| 2026-01-16 |
Tray Thomas |
Principal Accounting Officer |
RSU Award |
2,425 |
$106.21 |
$257.56K |
| 2026-01-20 |
Morrissey Michael James |
EVP, Head of Tech. Operations |
Tax Withholding of RSU |
429 |
$102.62 |
$44.02K |
| 2026-01-16 |
Morrissey Michael James |
EVP, Head of Tech. Operations |
RSU Award |
7,426 |
- |
- |
| 2026-01-16 |
Stein Steven H |
EVP & Chief Medical Officer |
RSU Award |
19,932 |
$106.21 |
$2.12M |
| 2026-01-16 |
Cagnoni Pablo J |
President, R&d |
RSU Award |
28,475 |
$106.21 |
$3.02M |
| 2026-01-07 |
Issa Mohamed Khairie |
EVP, Head of Us Oncology |
Informative Sell |
10,856 |
$109.07 |
$1.18M |
| 2026-01-06 |
Issa Mohamed Khairie |
EVP, Head of Us Oncology |
Tax Withholding of RSU |
8,264 |
$106.66 |
$881.44K |
| 2026-01-05 |
Stein Steven H |
EVP & Chief Medical Officer |
Informative Sell |
15,634 |
$101.70 |
$1.59M |
| 2025-12-31 |
Morrissey Michael James |
EVP, Head of Tech. Operations |
Tax Withholding of RSU |
254 |
$98.77 |
$25.09K |
| 2025-12-31 |
Stein Steven H |
EVP & Chief Medical Officer |
Tax Withholding of RSU |
13,292 |
$98.77 |
$1.31M |
| 2025-12-31 |
Clancy Paul J |
Director |
RSU Award |
241 |
$98.77 |
$23.8K |
| 2025-12-31 |
Baker Bros. Advisors Lp |
10 Percent Owner |
RSU Award |
328 |
- |
- |
| 2025-12-31 |
Harrigan Edmund |
Director |
RSU Award |
245 |
$98.77 |
$24.2K |
